74 filings
Page 4 of 4
8-K
a1lm5raq3r28 rni1oi8
14 Mar 18
Other Events
12:00am
8-K
ophqxv0v aejb71
5 Mar 18
Spring Bank Pharmaceuticals Appoints Timothy Clackson, Ph.D., to its Board of Directors
12:00am
8-K
z0u3g8l kxi
16 Nov 17
Spring Bank Pharmaceuticals Announces Positive Top-Line Results from the Second Cohort of Part A of the Phase 2 ACHIEVE Trial
12:00am
8-K
4ulcmw n3z
5 Oct 17
Entry into a Material Definitive Agreement
12:00am
8-K
u4dyypzakto242jxz
21 Sep 17
Regulation FD Disclosure
12:00am
8-K
gnrbql nbjvo8gwq
18 Aug 17
Entry into a Material Definitive Agreement
12:00am
8-K
yy4x6was6er7a
10 Jul 17
Other Events
12:00am
8-K
s28zn4hc3
23 Jun 17
Spring Bank Pharmaceuticals Prices $37.5 Million Public Offering of Common Stock
12:00am
8-K
5h6zyl
21 Jun 17
Spring Bank Pharmaceuticals Announces Proposed Public Offering of Common Stock
12:00am
8-K
2pbev
15 Jun 17
Submission of Matters to a Vote of Security Holders
12:00am
8-K
scbeuifcy hlnzc6ad7
23 May 17
Other Events
12:00am
8-K
wtc9kpdefo8zj8pma
21 Nov 16
Spring Bank Pharmaceuticals Announces Financing of $15 Million
12:00am
8-K
rmv4c
29 Jul 16
Spring Bank Pharmaceuticals Appoints Dr. Todd C. Brady to its Board of Directors
12:00am
8-K
x33zca n3i
13 May 16
Unregistered Sales of Equity Securities
12:00am